ENTITY: - **Thermo Fisher Scientific**
DATE: 13-03-2026

**Forensic Audit Memo – Thermo Fisher Scientific (Life Sciences & Genomics)**

**Objective:** Conduct a forensic review of financial transactions, data integrity, and compliance controls within Thermo Fisher Scientific’s Life Sciences & Genomics division.

**Scope:** Examine high-risk areas including R&D expenditures, supply chain transactions, and regulatory reporting for anomalies, fraud indicators, or control weaknesses.

**Methodology:** Deploy data analytics, transactional sampling, and system logs to identify discrepancies, unauthorized access, or misreporting.

**Deliverable:** Provide a detailed report with findings, risk assessments, and remediation recommendations by [date].

**Confidentiality:** Maintain strict confidentiality per corporate and regulatory protocols.

*[Prepared by: Forensic Audit Team]*

*(Technical, concise, and action-oriented.)*

[NOTARIZED BY 2A AGENCY]